On another call <a href=" http://iibf.uludag.edu.tr/?can-i-buy-acyclovir-over-the-counter-in-the-usa.pdf ">where to buy acyclovir 400 mg </a> After splitting off its drug unit from the medical device portion of the company on Jan. 1, Abbott is clearly using this large-scale deal to further bolster its profile as a medical device manufacturer. According to the company&#8217;s press release, &#8220;The $500 million market for peripheral artery disease, a blockage in the leg arteries that affects about 27 million people in the U.S. and Europe, is fueled by rising obesity and diabetes rates.&#8221; This, combined with the fact that traditional heart stent sales continue to lag, makes the acquisition of IDEV particularly strategic for Abbott going forward.